Subscription Center
The International AIDS Conference is being held in the U.S. for the first time since 1990. What progress have we made in battling this global disease since then?
July 20, 2012 |
News
A baby born exposed to the AIDS-causing virus received aggressive treatment that appears to have cured the child, and promises to spark new avenues for future research as well
Scientific American Magazine
Current efforts are failing to contain the infection
Scientific American Magazine
Scientists have rid one man of HIV by preventing the virus from entering certain immune cells. But the treatment was dangerous and likely unrepeatable. Can they figure out a safer, more broadly achievable way to help millions more?
Features
Researchers have found new ways to interfere with a co-receptor important to HIV infection, and the outcomes so far are encouraging
People who manage their HIV infections from an early stage are able to work more and keep their kids in school
Is it possible? The United Nations agency thinks so. To see why, follow an HIV-positive mom and her baby as they go through an 18-month HIV-transmission prevention program
Thirty years of struggle and research have led to dozens of treatments for HIV/AIDS--although both a cure and an effective vaccine remain elusive
Success of a vaginal microbicide gel reveals how HIV-prevention strategies can emerge from progress in treatment
Hope for quelling the spread of HIV to coming generations of children born to mothers with the disease
Are "elite controllers" the key to understanding HIV infection—and do their immune systems offer a new approach to developing an AIDS vaccine?
Despite questions, the Thailand trial spreads optimism
HIV-negative gay and bisexual men who took prophylactic antiretrovirals regularly were less likely to become infected
Science gets closer, but a fully effective vaccine remains elusive
Vaginal gel liquefies to release an antiviral drug in response to semen
HIV transmission due to needle sharing could be greatly reduced by changing syringe design to ensure less trapped blood. Gretchen Cuda Kroen reports
A rare group of HIV-positive individuals need no medicine to keep the virus in check. Their good fortune could point the way to more powerful treatments--and perhaps a vaccine
An entry ban, which went into effect in the 1980s, was lifted in late 2009
The Bush administration's international AIDS program has been hailed as a success story, but will President-elect Obama follow through with a higher quality, fewer-strings-attached plan?
Eliminating HIV from the body would require flushing the virus out of its hiding places and preventing those reservoirs from being refilled. A tall order but perhaps not impossible
In their first collaborative article 20 years ago, 2008 Nobel Prize winner Luc Montagnier, along with Robert Gallo, co-investigators who discovered HIV, introduced a Scientific American single-topic issue on AIDS. They recounted the breakthrough and offered prospects for vaccine, for therapy and for the epidemic
See what we're tweeting about
BoraZ Oh, Spring http://t.co/A8B86eYATp
docfreeride More proof against intelligent design: healing wound that will heal much better if you don't scratch 'em itch like nobody's business. docfreeride At Scientopia: A shift in the MOOCmentum (part 5): @tressiemcphd on what MOOCs learned from for-profit colleges
http://t.co/5LQV02kgUp
Deadline: Jul 25 2013
Reward: Varies
This challenge provides an opportunity for Solvers to build a web-based or mobile “app” to explore data relationships in scholarly conte
Deadline: Aug 31 2013
Reward: $100,000 USD
The Geoffrey Beene Foundation Alzheimer’s Initiative (GBFAI) is launching the 2013 Geoffrey Beene Global NeuroDiscovery Challenge whose
Powered By: 
YES! Send me a free issue of Scientific American with no obligation to continue the subscription. If I like it, I will be billed for the one-year subscription.
